<?xml version="1.0" encoding="iso-8859-1"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>HHS/OIG, Audit -&quot;Review of Epogen Internal Control Procedures at Massachusetts Renex Dialysis Clinics for Calendar Year 1999,&quot;(A-01-02-00502)</title>
<meta name="Keywords" content="Review of Epogen Internal Control Procedures at Massachusetts Renex Dialysis Clinics for Calendar Year 1999, A-01-02-00502, Audit Report, September 25, 2002, HHS Office of Inspector General, Office of Audit Services, (OAS), Centers for Medicare and Medicaid Services (CMS), Medicare, EndStage Renal Disease/Dialysis" />
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
</head>




<body>

<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-JLFR"
height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({"gtm.start":new Date().getTime(),event:"gtm.js"});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!="dataLayer"?"&l="+l:"";j.async=true;j.src="//www.googletagmanager.com/gtm.js?id="+i+dl;f.parentNode.insertBefore(j,f);})(window,document,"script","dataLayer","GTM-JLFR");</script>
<!-- End Google Tag Manager -->


  


<h2><em><!-- #BeginLibraryItem "/Library/top anchor.lbi" --><a name="top" id="top"></a><!-- #EndLibraryItem -->Department
    of Health and Human Services</em></h2>
<h3>&quot;Review of Epogen Internal Control Procedures at Massachusetts Renex Dialysis Clinics for Calendar Year 1999,&quot; (A-01-02-00502)</h3>
<h3>September 25, 2002 </h3>
<hr noshade="noshade" />
<p><a href="10200502.pdf">Complete
    Text of Report</a> is available in PDF format (2.93 MB). Copies can also be obtained by contacting the Office of Public
    Affairs at 202-619-1343.</p>
<hr noshade="noshade" />
<p><strong>EXECUTIVE SUMMARY:</strong></p>
<p>The objective of this review was to determine if Massachusetts Renex providers have established adequate internal controls
  and procedures to ensure that claims for EPOGEN (EPO) are supported and billed in accordance with Medicare rules and regulations.&nbsp; Based
  on a review of 296 claims valued at $327,540, we identified portions of 85 claims totaling $6,016 not eligible for Medicare
  reimbursement.&nbsp; We recommended that Renex (1) continue to strengthen their internal controls and procedures to ensure
  that the claims submitted for EPO are supported and billed in accordance with Medicare rules and regulations, and (2) refund
  the Medicare program $6,016 for unallowable Medicare costs to the fiscal intermediary BC/BS of Georgia. </p>
<!-- #BeginLibraryItem "/Library/bottom.lbi" -->

<!-- #EndLibraryItem --></body>
</html>
